Vascular Biogenics reported 0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Bluebird Bio BLUE:US $ 0M 0M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Eleven Biotherapeutics EBIO:US $ 0 0
Epizyme EPZM:US $ 232.9M 411K
Infinity Pharmaceuticals INFI:US $ 0M 0M
Prothena PRTA:US 0 0